A single microfluidic chip with dual surface properties for protein drug delivery

[Display omitted] Principles of double emulsion generation were incorporated in a glass microfluidic chip fabricated with two different surface properties in order to produce protein loaded polymer microspheres. The microspheres were produced by integrating two microfluidic flow focusing systems and...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 521; no. 1-2; pp. 84 - 91
Main Authors Bokharaei, Mehrdad, Saatchi, Katayoun, Häfeli, Urs O.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.04.2017
Subjects
Online AccessGet full text
ISSN0378-5173
1873-3476
1873-3476
DOI10.1016/j.ijpharm.2017.02.026

Cover

More Information
Summary:[Display omitted] Principles of double emulsion generation were incorporated in a glass microfluidic chip fabricated with two different surface properties in order to produce protein loaded polymer microspheres. The microspheres were produced by integrating two microfluidic flow focusing systems and a multi-step droplet splitting and mixing system into one chip. The chip consists of a hydrophobic and a hydrophilic section with two different heights, 12μm and 45μm, respectively. As a result, the protein is homogenously distributed throughout the polymer microsphere matrix, not just in its center (which has been studied before). In our work, the inner phase was bovine serum albumin (BSA) in phosphate buffered saline, the disperse phase was poly (lactic acid) in chloroform and the continuous phase was an aqueous solution of poly(vinyl alcohol). After solvent removal, BSA loaded microspheres with an encapsulation efficiency of up to 96% were obtained. Our results show the feasibility of producing microspheres loaded with a hydrophilic drug in a microfluidic system that integrates different microfluidic units into one chip.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-5173
1873-3476
1873-3476
DOI:10.1016/j.ijpharm.2017.02.026